Real-life effectiveness of indacaterol/glycopyrronium/mometasone for symptomatic relief of cough after switching from inhaled corticosteroid/long-acting β(2)-agonist therapy in patients with asthma: REACH study design

Cough is a major symptom in patients with asthma and poses a significant burden compared with other asthma symptoms. However, there are no approved treatments in Japan, developed to specifically treat cough in patients with asthma. We present the design of REACH, an 8-week real-life study, which wil...

Descripción completa

Detalles Bibliográficos
Autores principales: Niimi, Akio, Kanemitsu, Yoshihiro, Tajiri, Tomoko, Sumi, Kazuya, Mikami, Toshiaki, Kondo, Norihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Study Protocols
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052813/
https://www.ncbi.nlm.nih.gov/pubmed/37009022
http://dx.doi.org/10.1183/23120541.00452-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052813/
https://www.ncbi.nlm.nih.gov/pubmed/37009022
http://dx.doi.org/10.1183/23120541.00452-2022

Ejemplares similares